List of Excipients in API metformin hydrochloride extended-release tablets
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing metformin hydrochloride extended-release tablets
Detailed excipient profiles for metformin hydrochloride extended-release tablets
Excipient focus: ACETONE
metformin hydrochloride extended-release tablets drug variants containing ACETONE
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing ACETONE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A
metformin hydrochloride extended-release tablets drug variants containing AMMONIO METHACRYLATE COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
metformin hydrochloride extended-release tablets drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
metformin hydrochloride extended-release tablets drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSPOVIDONE
metformin hydrochloride extended-release tablets drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing CROSPOVIDONE
Excipient focus: FERROSOFERRIC OXIDE
metformin hydrochloride extended-release tablets drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
metformin hydrochloride extended-release tablets drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
metformin hydrochloride extended-release tablets drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
metformin hydrochloride extended-release tablets drug variants containing MAGNESIUM STEARATE
metformin hydrochloride extended-release tablets drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
metformin hydrochloride extended-release tablets drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
metformin hydrochloride extended-release tablets drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
metformin hydrochloride extended-release tablets drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
metformin hydrochloride extended-release tablets drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
metformin hydrochloride extended-release tablets drug variants containing POVIDONE
metformin hydrochloride extended-release tablets drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
metformin hydrochloride extended-release tablets drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
metformin hydrochloride extended-release tablets drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
metformin hydrochloride extended-release tablets drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
metformin hydrochloride extended-release tablets drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
metformin hydrochloride extended-release tablets drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
metformin hydrochloride extended-release tablets drug variants containing TITANIUM DIOXIDE
metformin hydrochloride extended-release tablets drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
metformin hydrochloride extended-release tablets drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
metformin hydrochloride extended-release tablets drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-445 |
| ScieGen Pharmaceuticals Inc | metformin hydrochloride extended-release tablets | 50228-503 |
| >Company | >Ingredient | >NDC |
metformin hydrochloride extended-release tablets drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| AiPing Pharmaceutical Inc | metformin hydrochloride extended-release tablets | 11788-037 |
| Qingdao BAHEAL Pharmaceutical Co Ltd | metformin hydrochloride extended-release tablets | 70247-018 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
